1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Marketing - What a joke

Discussion in 'Pfizer Animal Health' started by Anonymous, May 9, 2013 at 5:32 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Knock Knock:: Who is there?? Nobody

    Most all the marketers have quit and left the turquoise halls of FP. There are still a couple good ones left but how long they will last is anyone's guess?? You can't ask 2 or 3 good remaining marketers to do the job of all those that left for greener pastures.

    Managers, do things right. Leaders, do the right thing.

  2. Anonymous

    Anonymous Guest

    Are you losers still in the field? Damn they need to change the name of your company to "Easy Pickens"
  3. anonymous

    anonymous Guest

    Rimadyl is not as safe as its made out to be .